MyDx Launching AquaDx Sensor to Test for Harmful Chemicals

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MyDx Launching AquaDx Sensor to Test for Harmful Chemicals in Water; Company Accepting Pre-Orders for December Delivery

LA JOLLA, Calif., Sept. 15, 2016 (GLOBE NEWSWIRE) -- MyDx, Inc. (OTCQB:MYDX), a rapidly growing chemical detection company and the makers of MyDx ® , the first multi-use hand-held chemical analyzer for consumers, today announced it is launching its AquaDx™ sensor chip for the analysis of toxic chemicals in water, and is now accepting pre-orders at special pricing for early adopters.  The AquaDx Sensor works interchangeably with the MyDx Analyzer and, along with the CannaDx ™ sensor, is the second of its four different sensors -- with OrganaDx™ (tests organic fruits and vegetables) and AeroDx™ (tests air quality) both in beta stage and also slated for launch in the coming months.

A photo accompanying this announcement is available at  http://www.globenewswire.com/NewsRoom/Attachm...e7a004919f

MyDx Early Adopters Win  For a limited time, the Company is running a special AquaDx pre-order promotion. New MyDx customers ordering the multi-use Analyzer and AquaDx Electronic Sensor Chip will receive a $100 discount, plus ten free single-use AquaDx sensors and free shipping and handling. Existing MyDx Analyzer owners will receive the AquaDx Electronic Sensor Chip plus ten free single-use AquaDx sensors and a free Multi-Use retrofit upgrade kit ($99 value) and free shipping and handling, for $69.95.  AquaDx delivery is scheduled for December 15. For more info about AquaDx and pre-order details, visit: https://www.cdxlife.com/aqua-sensor/ . 

MyDx Analyzer Applications Growing: AquaDx Addresses $3 Billion Growth Market The global addressable market for water testing and analysis instruments is approximately $2.9 billion, and projected to grow at compound annual growth rate of 5.2% to reach $3.5 billion by 2019. By putting sophisticated water chemical test and analysis technology in the palm of consumers’ hands, conveniently and affordably, the Company expects its next-generation AquaDx technology will disrupt and significantly expand the global marketplace for water testing.

The Next Generation of Consumer-Grade Water Quality Testing Just as it does for the CannaDx sensor, the MyDx Analyzer connects the AquaDx sensor by Bluetooth to a smart phone app (iOS and Android) that uploads and aggregates big data analytics and downloads a comprehensive report to the consumer within minutes. The AquaDx application will offer three different one-time disposable sensors, for:

  1. Pesticides and Heavy Metals (Set to US Military Standards)
  2. Lead (Set to EPA Standards, Think Flint Michigan water health crisis)
  3. Total Hardness, Total Chlorine, pH and Total Alkalinity (Many municipalities use chlorine to “purify” their water. Alkalinity and pH of the body must stay within a narrow range to be healthy and accordingly, in recent years, the scientific community places increasing importance on the alkalinity of the food and water we consume.)

AquaDx features include:

  1. Real-time detection of toxic chemicals in drinking water
  2. Tests for pesticides, heavy metals and other neurotoxin chemicals to the US Military Exposure Guideline (MEG) for Safety
  3. Easy to use, pass/fail results within six minutes
  4. Handheld, battery operated, fits in your back pocket
  5. Track your data, share on social media, print results

AquaDx provides its users with a Total Toxicity Profile™ (TTP), a proprietary measurement that reports a Pass or Fail based on the presence of neurotoxic chemicals in water at concentrations that exceed the US Military Exposure Guideline (MEG) for drinking water (assuming 7-14 day exposure, 15L/day consumption, 70kg person) and are below the estimated Human Lethal Consumption (HLC) guideline. This test covers key organophosphate/carbamate pesticides and toxic heavy metals.

Dramatic Boost to Earnings Power and Ensuring Safe Water for All Commenting on the AquaDx launch, Daniel R. Yazbeck, MyDx Chairman and CEO, said, “Unlike our popular CannaDx analyzer, which addresses a rapidly growing $5 billion legal cannabis market whose product quality is largely unregulated, the AquaDx analyzer potentially addresses everyone on the planet who drinks water.

“The Flint Michigan poisoned water health crisis is only the most recent and highly publicized incident of its type; there are many others,” he added. See the July 28, CNN article featuring MyDx on this subject at: http://money.cnn.com/2016/07/28/technology/wa...index.html .

“While AquaDx is highly anticipated to provide a dramatic increase to our earnings power, this launch is especially gratifying for myself and all MyDx employees at a personal level given that everyone, worldwide, should have access to clean, safe drinking water. AquaDx will empower consumers to test their water safety in a simple and practical way,” Mr. Yazbeck concluded. “I invite all MyDx shareholders to share in the pride and satisfaction of helping to commercialize the important health benefit our AquaDx will provide consumers globally.”

About MyDx, Inc. MyDx, Inc. (OTCQB:MYDX) is a chemical detection and sensor technology company based in San Diego, California whose mission is to help people Trust & Verify ® what they put into their minds and bodies. The Company developed MyDx ® , a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of the user’s hand. The multi-use MyDx analyzer leverages over a decade of established technology to measure chemicals of interest. It owns a substantial and growing intellectual property portfolio of patents covering its technology. With its CannaDx™ sensor commercialized, it has three other sensors being developed in its lab that are compatible with the MyDx Analyzer and App that will empower consumers to test the chemical composition of everything they eat, drink and inhale.  For more information, please visit  www.cdxlife.com .

Forward-Looking Statements This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at http://ir.cdxlife.com/all-sec-filings or www.sec.gov .

The photo is also available at Newscom, www.newscom.com , and via AP PhotoExpress.

Investor Contact: Phillip Sugarman, Vice President Investor Relations Partners Phone: 818-280-6800 psugarman@irpartnersinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 361

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 280

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 102

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 70

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 256

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 158

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 127

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading

Top 5 Most Recently Viewed Articles

What Your $1000 Investment in ASML Could Be Worth Now

Updated Category News Views 269

Exploring ASML Holding's Remarkable Growth ASML Holding (NASDAQ: ASML) has established itself as a leader in the semiconductor industry, offering substantial growth for investors. Over the past 15 years, the stock has consistently outperformed the market, delivering an impressive annualized return of 23.78%. This performance exceeds the overall market's growth by 11.35%,...

Continue Reading
Nvidia and Adobe Lead Stock Movement Trends This Week

Updated Category News Views 87

Significant Stock Movements in Today's Market Today's trading session has brought notable activity in the stock market, particularly among mega-cap and large-cap companies. With significant price fluctuations and market activity, investors are closely analyzing trends influenced by various factors, such as earnings reports and market sentiment. Mega-Cap Market Movers When...

Continue Reading
Charlotte's Web Unveils Innovative Quiet Sleep Mushroom Gummies

Updated Category News Views 184

Charlotte's Web Launches Quiet Sleep Mushroom Gummies A recent survey highlights that 43% of Americans struggle with sleep due to racing thoughts. To address this common issue, Charlotte's Web Holdings, Inc. introduces a natural remedy in the form of Quiet Sleep Mushroom Gummies. These gummies are melatonin-free and free from CBD, utilizing the calming properties of...

Continue Reading
Brown Brothers Harriman Expands Team with New Senior Wealth Planner

Updated Category News Views 258

Brown Brothers Harriman Enhances Wealth Planning Services Brown Brothers Harriman & Co. (BBH) has taken a significant step in strengthening its Chicago presence by welcoming Kristina White as a Senior Wealth Planner. With years of experience as a Managing Director and Partner at McDermott Will & Emery, Kristina brings a wealth of expertise in sophisticated wealth...

Continue Reading
Hospitality Sector Innovates to Overcome Market Challenges

Updated Category News Views 78

Hospitality Sector Innovates to Tackle Market Challenges In recent years, hospitality stocks have contended with major obstacles, including economic uncertainties and shifts in global markets. Despite these challenges, this industry has shown remarkable resilience, continually adapting and innovating to thrive amid adversity. As Wall Street watches for economic changes,...

Continue Reading